CARISMA Therapeutics Announces First Patient Dosed in Landmark Clinical Study Evaluating Engineered Macrophages in Humans CARISMA Therapeutics Inc., a clinical stage biopharmaceutical company spun out of the University of Pennsylvania (Penn) and focused on discovering… read more

CEPI and VBI Vaccines Collaborate to Advance Vaccine Candidates Against COVID-19 Variants CEPI, the Coalition for Epidemic Preparedness Innovations, and VBI Vaccines Inc. (Nasdaq: VBIV), today announced a partnership to develop VBI’s enveloped… read more

GSK makes landmark pricing agreement for rotavirus vaccine, Rotarix, for use with children living in humanitarian crises As announced today by WHO, Médecins Sans Frontières (MSF), Save the Children and UNICEF, GSK has… read more

More than 1.7 million COVID-19 vaccines arrive in the Democratic Republic of Congo More than 1.7 million doses of COVID-19 vaccines have arrived in Kinshasa, the capital of the DRC. They were shipped… read more

AZD1222 US Phase III primary analysis confirms safety and efficacy 76% vaccine efficacy against symptomatic COVID-19100% efficacy against severe or critical disease and hospitalisation85% efficacy against symptomatic COVID-19 in participants aged 65 years… read more

ViaCyte Announces Initiation of Phase 2 Study of Encapsulated Cell Therapy for Type 1 Diabetes Patients ViaCyte, Inc., a clinical-stage regenerative medicine company, today announced that the first type 1 diabetes (T1D) patients… read more

Sumitomo Dainippon Pharma Oncology Announces Phase 3 CanStem303C Study of Napabucasin Fails to Reach Primary Endpoints in Patients with Previously Treated Metastatic Colorectal Cancer Sumitomo Dainippon Pharma Oncology, Inc., a developer of novel… read more

FDA Announces Advisory Committee Meeting to Discuss Janssen Biotech Inc.’s COVID-19 Vaccine Candidate The U.S. Food and Drug Administration has scheduled a meeting of its Vaccines and Related Biological Products Advisory Committee (VRBPAC)… read more

Sanofi and GSK Initiate Phase 2 Trial Of Adjuvanted Recombinant Protein-based COVID-19 Vaccine Candidate Sanofi and GSK announced today the initiation of a new Phase 2 study with 720 volunteers aged 18 and… read more

UCI Health Creates New Delivery System For Monoclonal Antibodies In COVID-19 Patients Monoclonal antibodies are showing promise for improving outcomes for COVID-19 patients, but when a hospital is already beyond capacity, administering them… read more